These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 30107868)

  • 41. The thrombogenicity of C1 esterase inhibitor (human): review of the evidence.
    Crowther M; Bauer KA; Kaplan AP
    Allergy Asthma Proc; 2014; 35(6):444-53. PubMed ID: 25584911
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks.
    Craig TJ; Levy RJ; Wasserman RL; Bewtra AK; Hurewitz D; Obtułowicz K; Reshef A; Ritchie B; Moldovan D; Shirov T; Grivcheva-Panovska V; Kiessling PC; Keinecke HO; Bernstein JA
    J Allergy Clin Immunol; 2009 Oct; 124(4):801-8. PubMed ID: 19767078
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of recombinant human C1 esterase inhibitor across anatomic locations in acute hereditary angioedema attacks.
    Baker JW; Bernstein JA; Harper JR; Relan A; Riedl MA
    Allergy Asthma Proc; 2018 Sep; 39(5):359-364. PubMed ID: 29954477
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Safety of a C1-inhibitor concentrate in pregnant women with hereditary angioedema.
    Fox J; Vegh AB; Martinez-Saguer I; Wuillemin WA; Edelman J; Williams-Herman D; Rojavin M; Rosenberg T
    Allergy Asthma Proc; 2017 May; 38(3):216-221. PubMed ID: 28441992
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Successful Long-Term Prophylactic Treatment With Subcutaneous C1 Esterase Inhibitor in a Patient With Hereditary Angioedema.
    Hahn J; Nordmann-Kleiner M; Trainotti S; Hoffmann TK; Greve J
    J Pharm Pract; 2020 Dec; 33(6):907-911. PubMed ID: 31234699
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preventing Hereditary Angioedema Attacks in Children Using Cinryze®: Interim Efficacy and Safety Phase 3 Findings.
    Aygören-Pürsün E; Soteres D; Moldovan D; Christensen J; Van Leerberghe A; Hao J; Schranz J; Jacobson KW; Martinez-Saguer I
    Int Arch Allergy Immunol; 2017; 173(2):114-119. PubMed ID: 28662509
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recombinant human C1 esterase inhibitor for acute hereditary angioedema attacks with upper airway involvement.
    Riedl MA; Li HH; Cicardi M; Harper JR; Relan A
    Allergy Asthma Proc; 2017 Nov; 38(6):462-466. PubMed ID: 28903805
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Escalating doses of C1 esterase inhibitor (CINRYZE) for prophylaxis in patients with hereditary angioedema.
    Bernstein JA; Manning ME; Li H; White MV; Baker J; Lumry WR; Davis-Lorton MA; Jacobson KW; Gower RG; Broom C; Fitts D; Schranz J
    J Allergy Clin Immunol Pract; 2014; 2(1):77-84. PubMed ID: 24565773
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Outcomes of long term treatments of type I hereditary angioedema in a Turkish family.
    Akoglu G; Kesim B; Yildiz G; Metin A
    An Bras Dermatol; 2017; 92(5):655-660. PubMed ID: 29166502
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of a C1 Inhibitor Concentrate in Adults ≥65 Years of Age with Hereditary Angioedema: Findings from the International Berinert
    Bygum A; Martinez-Saguer I; Bas M; Rosch J; Edelman J; Rojavin M; Williams-Herman D;
    Drugs Aging; 2016 Nov; 33(11):819-827. PubMed ID: 27699634
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nanofiltered human C1 inhibitor concentrate (Cinryze®): in hereditary angioedema.
    Lyseng-Williamson KA
    BioDrugs; 2011 Oct; 25(5):317-27. PubMed ID: 21942916
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of time to treatment on response to C1 esterase inhibitor concentrate for hereditary angioedema attacks.
    Craig TJ; Rojavin MA; Machnig T; Keinecke HO; Bernstein JA
    Ann Allergy Asthma Immunol; 2013 Sep; 111(3):211-5. PubMed ID: 23987198
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Indirect comparison of intravenous vs. subcutaneous C1-inhibitor placebo-controlled trials for routine prevention of hereditary angioedema attacks.
    Bernstein JA; Li HH; Craig TJ; Manning ME; Lawo JP; Machnig T; Krishnarajah G; Fridman M
    Allergy Asthma Clin Immunol; 2019; 15():13. PubMed ID: 30899278
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of hereditary angioedema with nanofiltered C1-esterase inhibitor concentrate (Cetor®): multi-center phase II and III studies to assess pharmacokinetics, clinical efficacy and safety.
    Hofstra JJ; Kleine Budde I; van Twuyver E; Choi G; Levi M; Leebeek FW; de Monchy JG; Ypma PF; Keizer RJ; Huitema AD; Strengers PF
    Clin Immunol; 2012 Mar; 142(3):280-90. PubMed ID: 22197071
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hereditary angioedema with normal C1 inhibitor: clinical characteristics and treatment response with plasma-derived human C1 inhibitor concentrate (Berinert
    Bouillet L; Boccon-Gibod I; Gompel A; Floccard B; Martin L; Blanchard-Delaunay C; Launay D; Fain O
    Eur J Dermatol; 2017 Apr; 27(2):155-159. PubMed ID: 28251901
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Angioedema due to acquired C1-inhibitor deficiency: spectrum and treatment with C1-inhibitor concentrate.
    Bork K; Staubach-Renz P; Hardt J
    Orphanet J Rare Dis; 2019 Mar; 14(1):65. PubMed ID: 30866985
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quality of life in patients with hereditary angioedema receiving therapy for routine prevention of attacks.
    Lumry WR; Miller DP; Newcomer S; Fitts D; Dayno J
    Allergy Asthma Proc; 2014; 35(5):371-6. PubMed ID: 25295804
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy of recombinant human C1 esterase inhibitor for the treatment of severe hereditary angioedema attacks.
    Li HH; Reshef A; Baker JW; Harper JR; Relan A
    Allergy Asthma Proc; 2017 Nov; 38(6):456-461. PubMed ID: 28874235
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of Different Medical Therapies for the Treatment of Acute Laryngeal Attacks of Hereditary Angioedema due to C1-esterase Inhibitor Deficiency.
    Bork K; Bernstein JA; Machnig T; Craig TJ
    J Emerg Med; 2016 Apr; 50(4):567-80.e1. PubMed ID: 26826769
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pasteurized and nanofiltered, plasma-derived C1 esterase inhibitor concentrate for the treatment of hereditary angioedema.
    Bork K
    Immunotherapy; 2014; 6(5):533-51. PubMed ID: 24635050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.